Literature DB >> 18418057

Distinct roles for p107 and p130 in Rb-independent cellular senescence.

Brian D Lehmann1, Adam M Brooks, Matthew S Paine, William H Chappell, James A McCubrey, David M Terrian.   

Abstract

Telomere attrition, DNA damage and constitutive mitogenic signaling can all trigger cellular senescence in normal cells and serve as a defense against tumor progression. Cancer cells may circumvent this cellular defense by acquiring genetic mutations in checkpoint proteins responsible for regulating permanent cell cycle arrest. A small family of tumor suppressor genes encoding the retinoblastoma susceptibility protein family (Rb, p107, p130) exerts a partially redundant control of entry into S phase of DNA replication and cellular proliferation. Here we report that activation of the p53-dependent DNA damage response has been found to accelerate senescence in human prostate cancer cells lacking a functional Rb protein. This novel form of irradiation-induced premature cellular senescence reinforces the notion that other Rb family members may compensate for loss of Rb protein in the DNA damage response pathway. Consistent with this hypothesis, depletion of p107 potently inhibits the irradiation-induced senescence observed in DU145 cells. In contrast, p130 depletion triggers a robust and unexpected form of premature senescence in unirradiated cells. The dominant effect of depleting both p107 and p130, in the absence of Rb, was a complete blockade of irradiation-induced cellular senescence. Onset of the p107-dependent senescence was temporally associated with p53-mediated stabilization of the cyclin-dependent kinase inhibitor p27 and decreases in c-myc and cks1 expression. These results indicate that p107 is required for initiation of accelerated cellular senescence in the absence of Rb and introduces the concept that p130 may be required to prevent the onset of terminal growth arrest in unstimulated prostate cancer cells lacking a functional Rb allele.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18418057      PMCID: PMC3474322          DOI: 10.4161/cc.7.9.5945

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  37 in total

1.  p27 destruction: Cks1 pulls the trigger.

Authors:  J Bartek; J Lukas
Journal:  Nat Cell Biol       Date:  2001-04       Impact factor: 28.824

2.  A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1.

Authors:  C Spruck; H Strohmaier; M Watson; A P Smith; A Ryan; T W Krek; S I Reed
Journal:  Mol Cell       Date:  2001-03       Impact factor: 17.970

3.  The cell-cycle regulatory protein Cks1 is required for SCF(Skp2)-mediated ubiquitinylation of p27.

Authors:  D Ganoth; G Bornstein; T K Ko; B Larsen; M Tyers; M Pagano; A Hershko
Journal:  Nat Cell Biol       Date:  2001-03       Impact factor: 28.824

4.  Relationship of finite proliferative lifespan, senescence, and quiescence in human cells.

Authors:  G H Stein; M Namba; C M Corsaro
Journal:  J Cell Physiol       Date:  1985-03       Impact factor: 6.384

5.  Wild-type but not mutant p53 can repress transcription initiation in vitro by interfering with the binding of basal transcription factors to the TATA motif.

Authors:  N Ragimov; A Krauskopf; N Navot; V Rotter; M Oren; Y Aloni
Journal:  Oncogene       Date:  1993-05       Impact factor: 9.867

6.  Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication.

Authors:  K Nakayama; H Nagahama; Y A Minamishima; M Matsumoto; I Nakamichi; K Kitagawa; M Shirane; R Tsunematsu; T Tsukiyama; N Ishida; M Kitagawa; K Nakayama; S Hatakeyama
Journal:  EMBO J       Date:  2000-05-02       Impact factor: 11.598

7.  Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles.

Authors:  W B Isaacs; B S Carter; C M Ewing
Journal:  Cancer Res       Date:  1991-09-01       Impact factor: 12.701

8.  Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene.

Authors:  R Bookstein; J Y Shew; P L Chen; P Scully; W H Lee
Journal:  Science       Date:  1990-02-09       Impact factor: 47.728

9.  p107 acts as a tumor suppressor in pRb-deficient epidermis.

Authors:  M Fernanda Lara; Mirentxu Santos; Sergio Ruiz; Carmen Segrelles; Marta Moral; Ana Belén Martínez-Cruz; Pilar Hernández; Jesús Martínez-Palacio; Corina Lorz; Ramón García-Escudero; Jesús M Paramio
Journal:  Mol Carcinog       Date:  2008-02       Impact factor: 4.784

10.  Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence.

Authors:  Masashi Narita; Sabrina Nũnez; Edith Heard; Masako Narita; Athena W Lin; Stephen A Hearn; David L Spector; Gregory J Hannon; Scott W Lowe
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

View more
  8 in total

1.  Rapamycin induces pluripotent genes associated with avoidance of replicative senescence.

Authors:  Tatiana V Pospelova; Tatiana V Bykova; Svetlana G Zubova; Natalia V Katolikova; Natalia M Yartzeva; Valery A Pospelov
Journal:  Cell Cycle       Date:  2013-12-02       Impact factor: 4.534

2.  Role of senescence and mitotic catastrophe in cancer therapy.

Authors:  Richa Singh; Jasmine George; Yogeshwer Shukla
Journal:  Cell Div       Date:  2010-01-21       Impact factor: 5.130

3.  What's so special about RB?

Authors:  Christin E Burd; Norman E Sharpless
Journal:  Cancer Cell       Date:  2010-04-13       Impact factor: 31.743

Review 4.  Tumor suppression by p53: making cells senescent.

Authors:  Yingjuan Qian; Xinbin Chen
Journal:  Histol Histopathol       Date:  2010-04       Impact factor: 2.303

Review 5.  The cell fate: senescence or quiescence.

Authors:  Menderes Yusuf Terzi; Muzeyyen Izmirli; Bulent Gogebakan
Journal:  Mol Biol Rep       Date:  2016-08-24       Impact factor: 2.316

6.  The relative contributions of the p53 and pRb pathways in oncogene-induced melanocyte senescence.

Authors:  Sebastian Haferkamp; Sieu L Tran; Therese M Becker; Lyndee L Scurr; Richard F Kefford; Helen Rizos
Journal:  Aging (Albany NY)       Date:  2009-05-16       Impact factor: 5.682

7.  MicroRNAs181 regulate the expression of p27Kip1 in human myeloid leukemia cells induced to differentiate by 1,25-dihydroxyvitamin D3.

Authors:  Xuening Wang; Elzbieta Gocek; Chang-Gong Liu; George P Studzinski
Journal:  Cell Cycle       Date:  2009-03-18       Impact factor: 4.534

8.  Silencing of protein kinase D2 induces glioma cell senescence via p53-dependent and -independent pathways.

Authors:  Eva Bernhart; Sabine Damm; Petra Heffeter; Andrea Wintersperger; Martin Asslaber; Saša Frank; Astrid Hammer; Heimo Strohmaier; Trevor DeVaney; Manuel Mrfka; Hans Eder; Christian Windpassinger; Christopher R Ireson; Paul S Mischel; Walter Berger; Wolfgang Sattler
Journal:  Neuro Oncol       Date:  2014-07       Impact factor: 12.300

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.